THIO Sequenced With Cemiplimab in Advanced NSCLC

NCT05208944 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: 6-Thio-2'-Deoxyguanosine
DRUG: Cemiplimab

Sponsor

Maia Biotechnology